Impact of beta blockers on dobutamine-atropine stress echocardiography

Echocardiography

Volumn 13, Issue 4, 1996, Pages 373-380

  San Román, José Alberto ^a   Vilacosta, Isidre ^b   Rollán, María Jesús ^b   Castillo, Juan Antonio ^b   Sánchez Harguindey, Luis ^b   Avilés, Francisco Fernández ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

^b HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

beta blockers; dobutamine; stress echocardiography

Indexed keywords

ATROPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DOBUTAMINE; PROPRANOLOL;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; ECHOCARDIOGRAPHY; FEMALE; HEART MUSCLE ISCHEMIA; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTENSION; HYPOTENSION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

EID: 0030018030     PISSN: 07422822     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8175.1996.tb00908.x     Document Type: Article

References (16)

1. Sonnenblick EH, Frishman WH, Lejemtel TH: Dobutamine: A new synthetic cardioactive sympathetic amine. N Engl J Med 1979;300: 17-22.
2. Chatterjee K, De Marco T: Central and peripheral adrenergic receptor agonists in heart failure. Eur Heart J 1989;10(Suppl B): 55-63.
3. Sawada SG, Segar DS, Ryan T, et al: Echocardiographic detection of coronary artery disease during dobutamine infusion. Circulation 1991; 83:1605-1614.
4. Mazeika PK, Nadazdin A, Oakley CM: Dobutamine stress echocardiography for detection and assessment of coronary artery disease. JACC 1992;19:1203-1211.
5. Cohen JL, Greene TO, Ottenweller JD, et al: Dobutamine digital echocardiography for detecting coronary artery disease. Am J Cardiol 1991;67:1311-1318.
6. Berthe C, Pierard LA, Hiernaux M, et al: Predicting the extent and location of coronary artery disease in acute myocardial infarction by echocardiography during dobutamine infusion. Am J Cardiol 1986;58:1167-1172.
7. Mannering D, Cripps T, Leech G, et al: The dobutamine test is an alternative to exercise testing after acute myocardial infarction. Br Heart J 1988;59:521-526.
8. Poldermans D, Fioretti PM, Forster T, et al: Dobutamine stress echocardiography for assessment of perioperative cardiac risk in patients undergoing major vascular surgery. Circulation 1993;87:1506-1512.
9. Lalka SG, Sawada SG, Dalsing MC, et al: Dobutamine stress echocardiography as a predictor of cardiac events associated with aortic surgery. J Vasc Surg 1992;15:831-842.
10. Dávila-Román VG, Waggoner AD, Sicard GA, et al: Dobutamine stress echocardiography predicts surgical outcome in patients with an aortic aneurysm and peripheral vascular disease. JACC 1993;21:957-963.
11. Mazeika PK, Nadazdin A, Oakley CM: Prognostic value of dobutamine echocardiography in patients with high likelihood of coronary artery disease. Am J Cardiol 1993;71: 33-39.
12. Report from the American Society of Echocardiography committee on nomenclature and standards: identification of myocardial wall segments: November, 1982.
13. Marcovitz PA, Bach DS, Markarian M, et al: Beta blockade blunts heart rate and blood pressure response but not contractility augmentation during incremental dobutamine infusion. JACC 1992;19:278A.
14. McNeill AJ, Fioretti PM, El Said SM, et al: Enhanced sensitivity for detection of coronary artery disease by addition of atropine to dobutamine stress echocardiography. Am J Cardiol 1992;70:41-46.
15. Picano E, Lattanzi F, Masini M, et al: Different degrees of ischemic threshold stratified by the dipyridamole-echocardiography test. Am J Cardiol 1987;59:71-73.
16. Picano E: Stress echocardiography. From pathophysiological toy to diagnostic tool. Circulation 1992;85:1604-1612.